Document is current
Any future updates will be listed below
-
Authors
McKenzie, Katelyn A. http://orcid.org/0000-0002-8784-0509
El Ters, Mirelle
Torres, Vicente E.
Harris, Peter C.
Chapman, Arlene B.
Mrug, Michal
Rahbari-Oskoui, Frederic F.
Bae, Kyongtae Ty
Landsittel, Douglas P.
Bennett, William M.
Yu, Alan S. L.
Mahnken, Jonathan D.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (DK106912)
National Institute of Diabetes and Digestive and Kidney Diseases (DK056943, DK056956, DK056957, DK056961)
- License Information
-
More Information
Article History
Received: 19 March 2018
Accepted: 10 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: Each participant in the CRISP study signed an informed consent to participate in the study. The study was approved by the Institutional Review Board (IRB) at the University of Kansas Medical Center (STUDY00141151).
: No individual level data was presented in this manuscript.
: VET, PCH and MM have received research funding from Otsuka Pharmaceuticals. FFR is a consultant for Keryx and Kadmon and has received research funding from Otsuka and Genzyme. ABC is a consultant for Otsuka, Pfizer and Sanofi, and has received research funding from Boston Scientific, Kadmon and Otsuka. MM is also a consultant for Otsuka and Sanofi. All other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
